![Noel Donnelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noel Donnelly
Directeur Financier/CFO chez
PEPGEN INC.
Fortune : 26 022 $ au 31/05/2026
Profil
Noel Donnelly is currently an Independent Non-Executive Director at Radiopharm Theranostics Ltd. since 2024 and Chief Financial Officer at PepGen Inc. since 2021.
Formerly, Mr. Donnelly was Chief Financial Officer at EIP Pharma, Inc. from 2019 to 2021.
Education includes an MBA from Babson College and an undergraduate degree from the University of Massachusetts Lowell.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PEPGEN INC. 0,03 % | 31/03/2026 | 17 348 ( 0,03 % ) | 26 022 $ | 31/05/2026 |
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Noel Donnelly
| Sociétés | Poste | Début |
|---|---|---|
| PEPGEN INC. | Directeur Financier/CFO | 01/10/2021 |
| RADIOPHARM THERANOSTICS LIMITED | Directeur/Membre du Conseil | 01/10/2024 |
Anciens postes connus de Noel Donnelly
| Sociétés | Poste | Fin |
|---|---|---|
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Directeur Financier/CFO | 01/10/2021 |
Formation de Noel Donnelly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts Lowell
 University of Massachusetts Lowell Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Radiopharm Theranostics Ltd.
 Radiopharm Theranostics Ltd. Medical/Nursing ServicesHealth Services Provides nuclear diagnostic services | Health Services |
